Palleon Pharmaceuticals Funding: $147M Raised, Series B
Palleon Pharmaceuticals is based in Waltham. It has raised $147M in total funding. Latest round: Series B.
Palleon Pharmaceuticals funding overview
Palleon Pharmaceuticals is based in Waltham. Palleon Pharmaceuticals has raised $147M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2020. The round record for Palleon Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Matrix Capital Management, SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, AbbVie Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Palleon Pharmaceuticals at a glance
Total raised
$147M
Latest round
Series B
Latest round date
September 2020
Headquarters
Waltham
Notable investors
Matrix Capital Management, SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, AbbVie Ventures, Surveyor Capital
Frequently asked about Palleon Pharmaceuticals funding
How much has Palleon Pharmaceuticals raised?
Palleon Pharmaceuticals has raised $147M in total disclosed funding across the rounds on record.
Who has invested in Palleon Pharmaceuticals?
Matrix Capital Management, SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, AbbVie Ventures are named among the investors backing Palleon Pharmaceuticals.
What was the latest Palleon Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in September 2020.
Where is Palleon Pharmaceuticals based?
Palleon Pharmaceuticals is based in Waltham.
When did Palleon Pharmaceuticals last raise?
The last disclosed Palleon Pharmaceuticals round closed in September 2020 at Series B.
Totals shown for Palleon Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Waltham and the investors behind them below.
